Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2018-11-02 Regulatory Filings
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document contains only placeholders for pictures and no textual content or financial data. It is extremely short (222 characters) and does not contain any report, announcement, or detailed information. Therefore, it cannot be classified as a substantive report or announcement. Given the lack of content, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2018-11-02 English
Updates
Regulatory Filings
2018-10-29 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled 'Minutes of the 24th Annual General Meeting' and details the proceedings of the AGM held on September 29, 2018. It includes information about the meeting attendees, chairman election, resolutions passed including adoption of audited financial statements, dividend declaration, director appointments and re-appointments, and other business conducted during the AGM. The document is a detailed record of the AGM proceedings rather than a presentation, report, or announcement of voting results. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a voting results declaration (DVA). The content aligns with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting, including minutes. The document length (15,000 characters) and detailed content confirm it is the actual minutes, not a brief announcement or notice. Therefore, the correct classification is AGM Information (AGM-R).
2018-10-24 English
Updates
Regulatory Filings Classification · 100% confidence The document contains only placeholders for images and no textual content or substantive information. It is extremely short (223 characters) and does not contain any financial data, report content, or announcements. Given the lack of content, it cannot be classified as a report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2018-10-15 English
Shareholders meeting
Regulatory Filings
2018-10-01 English
Shareholders meeting
Regulatory Filings
2018-09-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.